查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451711

2024-2032 年按类型、技术（微阵列、即时定量聚合酶炼式反应、定序技术）、应用、最终用户和地区分類的转录组学市场报告

Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球转录组学市场规模达到72亿美元。展望未来， IMARC Group预计到2032年市场规模将达到118亿美元，2024-2032年复合年增长率（CAGR）为5.44%。

转录组学是对任何生物的基因型在特定时间、条件或细胞产生的核糖核酸 (RNA) 转录本的分析。它将基因组、蛋白质组和细胞表型连结起来。转录组学涵盖与 RNA 相关的一切，包括它们的转录和表达水平、功能、位置、运输和降解。转录组学利用微阵列分析、即时定量聚合酶炼式反应 (Q-PCR) 和定序技术来确定基因的转录结构。它还帮助研究人员表征转录活性，重点关注相关目标基因和转录本的子集，并识别响应和抵消生物和非生物环境胁迫的基因和途径。

转录组学市场趋势：

全球对个人化医疗的需求不断增长，为市场创造了积极的前景。由于 PCR 应用数量的增加以及该领域的进步（例如 RNA 定序的广泛使用），转录组学得到了广泛的应用。与此一致的是，在研究应用中获取遗传资讯对RNA定序的需求不断增长也有利于市场的成长。 RNA 定序彻底改变了转录组分析，能够在单一研究中量化基因表现水平，以及新基因、剪接亚型、融合转录本的亲和力，以及对非编码 RNA 领域的非凡研究。除此之外，主要参与者不断致力于开发疾病和诊断的新颖仪器和技术，这反过来又促进了市场成长。此外，推出具有全转录组定序 (WTS) 功能的先进基因分析产品，可提供详细的 RNA 定序分析，对市场成长产生了积极影响。除此之外，广泛的研究和开发（R＆D）活动、由于Covid-19疾病的爆发而对转录组学的需求不断增加，以及各种政府倡议和组学资金的实施正在支持市场的成长。

本报告回答的关键问题

  • 2023年全球转录组学市场规模有多大？
  • 2024-2032年全球转录组学市场的预期成长率是多少？
  • 推动全球转录组学市场的关键因素是什么？
  • COVID-19 对全球转录组学市场有何影响？
  • 全球转录组学市场按类型划分是怎样的？
  • 基于该技术的全球转录组学市场的细分情况如何？
  • 基于应用的全球转录组学市场的细分如何？
  • 全球转录组学市场的关键区域有哪些？
  • 全球转录组学市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球转录组市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 仪器
    • 市场走向
    • 市场预测
  • 耗材
    • 市场走向
    • 市场预测
  • 软体
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 微阵列
    • 市场走向
    • 市场预测
  • 即时定量聚合酶炼式反应 (Q-PCR)
    • 市场走向
    • 市场预测
  • 定序技术
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 诊断和疾病分析
    • 市场走向
    • 市场预测
  • 药物发现
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 学术及研究机构
    • 市场走向
    • 市场预测
  • 製药公司
    • 市场走向
    • 市场预测
  • 生技公司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • Biospyder Technologies Inc.
    • Illumina Inc.
    • Nanostring Technologies Inc.
    • Qiagen
    • Roche Holding AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A6585

The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.

Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.

Transcriptomics Market Trends:

The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.

Breakup by Type:

Instruments

Consumables

Software

Services

Breakup by Technology:

Microarray

Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)

Sequencing Technologies

Breakup by Application:

Diagnostics and Disease Profiling

Drug Discovery

Others

Breakup by End User:

Academic and Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global transcriptomics market in 2023?
  • 2. What is the expected growth rate of the global transcriptomics market during 2024-2032?
  • 3. What are the key factors driving the global transcriptomics market?
  • 4. What has been the impact of COVID-19 on the global transcriptomics market?
  • 5. What is the breakup of the global transcriptomics market based on type?
  • 6. What is the breakup of the global transcriptomics market based on the technology?
  • 7. What is the breakup of the global transcriptomics market based on the application?
  • 8. What are the key regions in the global transcriptomics market?
  • 9. Who are the key players/companies in the global transcriptomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcriptomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing Technologies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Diagnostics and Disease Profiling
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic and Research Institutes
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 BGI Group
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biospyder Technologies Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nanostring Technologies Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Qiagen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Roche Holding AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Takara Bio Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
  • Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Transcriptomics Industry: SWOT Analysis
  • Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
  • Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Transcriptomics Market: Competitive Structure
  • Table 8: Global: Transcriptomics Market: Key Players